Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Drug Discovery: Overview01:26

Drug Discovery: Overview

8.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.8K
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

259
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
259
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

156
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
156
Passive Diffusion: Overview and Kinetics01:17

Passive Diffusion: Overview and Kinetics

751
Passive diffusion is a critical process that allows small lipophilic drugs to cross the cell membrane along a concentration gradient. This mechanism's efficiency depends on four primary factors: the membrane's surface area, the drug's lipid-water partition coefficient, the concentration gradient, and the membrane's thickness.
When administered orally, drugs establish a substantial concentration gradient between the gastrointestinal (GI) lumen and the bloodstream, expediting...
751
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

153
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
153

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of 3-desoxycollinoketone B and its ability to reduce Alzheimer-associated misfolded proteins.

Nature communications·2026
Same author

Riemannian denoising model for molecular structure optimization with chemical accuracy.

Nature computational science·2026
Same author

Engineering Excited States of Pt-Based Deep-Blue Phosphors to Enhance OLED Stability.

ACS omega·2025
Same author

MetalloGen: Automated 3D Conformer Generation for Diverse Coordination Complexes.

Journal of chemical information and modeling·2025
Same author

Machine-Learning-Based Design of Metallocene Catalysts for Controlled Olefin Copolymerization.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Facilitating Transition State Search with Minimal Conformational Sampling Using Reaction Graph.

Journal of chemical theory and computation·2025
Same journal

Targeted Delivery of Indole-3-Pyruvic Acid Suppresses Macrophage Ferroptosis to Enhance CD8<sup>+</sup> T Cell-Mediated Immunotherapy Response in Bladder Cancer.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Pathological Copper Overload Reprograms SOD1 Activation via COMMD1 to Promote Senescence and Fibrosis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Bending-Resistant Intimate 3D Graphene-Metal Heterojunctions for Highly Sensitive and Robust Flexible Sensors.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Pathology-Instructed Theranostic Platform with Mechanoadaptive and ROS-Powered Nanobreathing Functions for Precision Myocardial Repair.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

Targeting p21-High Senescent Kupffer Cells Nanotherapeutically Potentiates Antitumor Immunity in Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same journal

A Ceramic Network for Hybrid Solid Electrolyte Lithium Metal Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
See all related articles

Related Experiment Video

Updated: Sep 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542

BInD: Bond and Interaction-Generating Diffusion Model for Multi-Objective Structure-Based Drug Design.

Joongwon Lee1, Wonho Zhung1, Jisu Seo1

  • 1Department of Chemistry, KAIST, Yuseong-gu, Daejeon, 34141, Republic of Korea.

Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|July 11, 2025
PubMed
Summary
This summary is machine-generated.

A new diffusion model, BInD, co-generates molecules and their protein interactions for structure-based drug design (SBDD). This approach balances molecular properties and target specificity, outperforming existing methods.

Keywords:
3D molecular generative modeldiffusion modelnon‐covalent interactionstructure‐based drug design

More Related Videos

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

Related Experiment Videos

Last Updated: Sep 16, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

542
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
10:58

Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules

Published on: July 25, 2013

17.2K
Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

1.5K

Area of Science:

  • Computational chemistry
  • Structural biology
  • Artificial intelligence in drug discovery

Background:

  • Advancements in geometric deep generative models and structural data enable structure-based drug design (SBDD) using only target protein information.
  • Existing models often struggle to balance multiple objectives, leading to suboptimal performance in specific tasks.

Purpose of the Study:

  • To introduce BInD, a novel diffusion model designed to co-generate molecules and their interactions with target proteins.
  • To address the limitations of existing models in balancing multiple objectives for SBDD.
  • To enhance target binding and specificity through molecule design and optimization.

Main Methods:

  • Development of BInD, a diffusion model incorporating knowledge-based guidance for co-generation.
  • Ensuring balanced consideration of target-specific interactions, molecular properties, and local geometry.
  • Implementation of an NCI-driven molecule design and optimization strategy.

Main Results:

  • BInD demonstrates robust performance across all key objectives, matching or surpassing state-of-the-art methods.
  • The model successfully co-generates molecules with balanced properties and target interactions.
  • The proposed optimization method enhances target binding and specificity.

Conclusions:

  • BInD offers a balanced approach to SBDD by co-generating molecules and their interactions.
  • The model represents a significant advancement in generative models for drug discovery.
  • The NCI-driven optimization further refines molecule design for improved therapeutic potential.